Khaitan & Co 
Corporate & In-House News

Khaitan & Co sets new record for itself with 76 campus hires in 2022

The average annual starting salary package will be around ₹15.6 lakh.

Bar & Bench

Khaitan & Co has hired a record 76 students during its 2022 campus recruitment drive.

Of the 76 newly recruited Associates, more than 50% (40) lawyers are women. The firm made 52 pre-placement offers (PPOs), while the remaining 24 were recruited on Day Zero.

The annual starting salary package will be around ₹15.6 lakh.

The firm hired 10 students from West Bengal National University of Juridical Sciences (WBNUJS), Kolkata, and 9 from Gujarat National Law University (GNLU), Gandhinagar. 7 students each were hired from National Law Institute University (NLIU), Bhopal and National Law University, Jodhpur (NLUJ). 6 each from National Academy of Legal Studies and Research (NALSAR), Hyderabad, National Law University, Odisha (NLUO) and Symbiosis Law School (SLS) Pune were hired by the firm.

Commenting on the 2022 campus recruits, Executive Director, Human Resources Amar Sinhji said,

"We are very proud to onboard the largest ever batch (76 Associates) in the history of our storied firm. In line with our belief in diversity, the batch also has more than 50% women! This has been consistent over the past couple of years now. The firm has always believed that the future belongs to those that prepare for it today and onboarding the best of the best from campus has been our long term talent strategy – growing our own talent has always taken priority over acquiring talent.

Justices Alok Aradhe and Vipul Pancholi sworn in as Supreme Court judges

Supreme Court rejects Presidential Reference for removal of AP Public Service Commission member

Delhi lawyers suspend strike after goverment decides to pause notification on police station depositions

Will affect livelihoods, investments: Head Digital Works challenges online money gaming ban in Karnataka High Court

Anthem Biosciences tells Delhi High Court it won't launch products using anti-cancer drug Alectinib

SCROLL FOR NEXT